Bailard, Inc. Edwards Lifesciences Corp Transaction History

Bailard, Inc.

$3.8 Billion
Q3 2024

A detailed history of Bailard, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bailard, Inc. holds 39,183 shares of EW stock, worth $2.93 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

39,183

Previous 55,226 29.05%

Holding current value

$2.93 Million

Previous $5.1 Million 49.32%

% of portfolio

0.07%

Previous 0.14%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$59.7 - $93.78 $957,767 - $1.5 Million	-16,043 Reduced 29.05%	39,183 $2.59 Million
Q2 2024 Jul 25, 2024	SELL	$84.3 - $94.31 $44,679 - $49,984	-530 Reduced 0.95%	55,226 $5.1 Million
Q1 2024 May 08, 2024	BUY	$72.54 - $95.56 $460,121 - $606,137	6,343 Added 12.84%	55,756 $5.33 Million
Q4 2023 Feb 02, 2024	SELL	$61.71 - $77.76 $445,422 - $561,271	-7,218 Reduced 12.75%	49,413 $3.77 Million
Q3 2023 Oct 24, 2023	BUY	$69.28 - $93.38 $54,661 - $73,676	789 Added 1.41%	56,631 $3.92 Million
Q2 2023 Jul 20, 2023	SELL	$81.41 - $94.33 $1.04 Million - $1.2 Million	-12,750 Reduced 18.59%	55,842 $5.27 Million
Q1 2023 May 08, 2023	SELL	$74.26 - $84.51 $26,733 - $30,423	-360 Reduced 0.52%	68,592 $5.67 Million
Q4 2022 Feb 02, 2023	SELL	$68.3 - $87.44 $82,984 - $106,239	-1,215 Reduced 1.73%	68,952 $5.14 Million
Q3 2022 Oct 18, 2022	BUY	$82.37 - $107.29 $56,176 - $73,171	682 Added 0.98%	70,167 $5.8 Million
Q2 2022 Jul 27, 2022	BUY	$86.5 - $128.27 $24,912 - $36,941	288 Added 0.42%	69,485 $6.61 Million
Q1 2022 Apr 25, 2022	BUY	$101.96 - $128.34 $291,095 - $366,410	2,855 Added 4.3%	69,197 $8.15 Million
Q4 2021 Feb 10, 2022	SELL	$106.37 - $130.68 $230,397 - $283,052	-2,166 Reduced 3.16%	66,342 $8.6 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $30,255 - $36,088	-294 Reduced 0.43%	68,508 $7.76 Million
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $6,455 - $8,066	-77 Reduced 0.11%	68,802 $7.13 Million
Q1 2021 May 13, 2021	BUY	$78.68 - $90.67 $5.42 Million - $6.25 Million	68,879 New	68,879 $5.76 Million
Q3 2020 Nov 10, 2020	SELL	$67.19 - $87.44 $197,807 - $257,423	-2,944 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$57.54 - $76.95 $169,397 - $226,540	2,944 New	2,944 $203,000
Q4 2019 Jan 31, 2020	SELL	$71.7 - $82.09 $69,333 - $79,381	-967 Closed	0 $0
Q3 2019 Oct 18, 2019	BUY	$61.55 - $75.43 $59,518 - $72,940	967 New	967 $213,000

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.

Account